Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

3.09
Delayed Data
As of Sep 22
 -0.0107 / -0.35%
Today’s Change
2.61
Today|||52-Week Range
8.40
-47.28%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close3.10
Today’s open3.08
Day’s range3.04 - 3.09
Volume2,379
Average volume (3 months)8,654
Market cap$14.9M
Dividend yield--
Data as of 2:12pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+79.05%
Earnings growth (this year)-58.23%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
CBIOCatalyst Biosciences...+0.40+9.05%
ABIOARCA Biopharma Inc+0.02+2.13%
OGENOragenics Inc+0.06+17.50%
ONTXOnconova Therapeutic...+0.02+1.12%
Data as of 7:59pm ET, 09/22/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Director-Finance &
Administration
Gabrielle Heaton
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts